Decreased NR1 and NR2A protein expression in 21-day group. by Chenxia Han (4020017)

“…The levels of both the NR1 <b>(A)</b> and NR2A <b>(B)</b> proteins of the 21-day group decreased compared with the control group, and the other two groups as well.…”

Inhibition of G9a decreases the tumorigenicity of neuroblastoma cells. by Xiao-Xue Ke (626989)

Decreased osteoclast formation by LDH-A or LDH-B depletion. by Heejin Ahn (3173670)

Resveratrol decreases cell proliferation in a time and dose dependent manner. by Mehtap Kilic Eren (591048)

RAC1 inhibition results in a decrease in oxidative phosphorylation. by Shruthi Sriramkumar (12705564)

Propofol induced cell death and decreased mitochondrial membrane potential in a concentration- and time-dependent manner. by Chisato Sumi (3521705)

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)

Decreasing fluconazole susceptibility of clinical South African <i>Cryptococcus neoformans</i> isolates over a decade by Serisha D. Naicker (8648370)

Hyperalgesia was assessed by a decrease in paw withdrawal threshold (PWT_50%) in a model of mild heat injury (MHI). by Manuel P. Pereira (417488)

Protocatechuic aldehyde decreases ROS production. by Byung Soo Kong (663779)

A2EN supernatants do not decrease cell-free HIV viability. by Lyndsey R. Buckner (843006)

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

mTORC1 hyperactivation led to a decreased autophagic activity in the podocytes. by Wakiko Iwata (8600457)

“…<p>(<b>A</b>) Primary cultured podocytes were isolated from <i>Tsc2</i>^{Δ<i>podocyte</i>} and wild-type controls, followed by western blot analyses of TSC2, phospho-4EBP1, LC3B type II, p62, phospho-ULK1, and β-tubulin. …”

Diclofenac decreases angiogenesis. by Nina Mayorek (241888)

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

Silencing of dynamin II decreases apoE secretion. by Maaike Kockx (154125)

Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability. by Giorgia Urbinati (554921)

“…One hundred percent cell viability corresponds to the number of living cells incubated with transfecting agent only. Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”

Correlations between mean skin conductance (SC), slope of the SC decrease during the rest period, state anxiety, and mean hand temperature (T C°) in the two study groups. by Gustavo A. Reyes del Paso (9579818)

“…<p>Correlations between mean skin conductance (SC), slope of the SC decrease during the rest period, state anxiety, and mean hand temperature (T C°) in the two study groups.…”

Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability. by Giorgia Urbinati (554921)

“…<p>VCaP cells were transfected for 24h, 48h and 72h with 50 nM of siRNAs TMPRSS2-ERG III (1, 2, 3), siRNAs TMPRSS2-ERG IV (1, 2), siRNA against ERG wild type or siRNA Control. …”

Calyculin A-induced decrease of tyrosine-monophosphorylated ERK2 at high cell density. by Noriyuki Kawabata (3391739)